by admin | Jan 19, 2023 | News & Updates
Sanzyme Biologics performs a systemic review of evidence and publishes a range of health claims for its flagship probiotic strain Bacillus coagulans SNZ 1969® with FSANZ. Standard 1.2.7 of the Food Standards Code provides a route for the food industry to...
by shivani | Oct 26, 2022 | News & Updates
Bacillus coagulans SNZ 1969®, a natural spore forming probiotic strain with five decades history of use and over 30 human studies across age groups found to be effective in managing IBS symptoms, demonstrates the latest clinical study. This study is unique as it...
by admin | Apr 2, 2021 | News & Updates
Hyderabad,24th March 2021, Among various drug and dietary supplement manufacturers and consumers, the Non-GMO project verification seal is the most trusted label, providing assurance that the products has completed a rigorous, unbiased evaluation for compliance with...
by admin | Feb 6, 2020 | News & Updates
Sanzyme Biologics has obtained Generally Recognized as Safe (GRAS) approval relating to use of Bacillus coagulans SNZ 1969™ in infant formula. The US Food & Drug Administration (FDA) issued the company with a GRAS Notice known as a ‘no objection letter’. It states...
by admin | Jan 30, 2020 | News & Updates
Sanzyme Biologics Pvt. Ltd is now registered with The NSF Dietary Supplement Certification Program which has assessed and confirmed compliance of its facility situated at Genome Valley, Hyderabad (Telangana). With the NSF certification, the company is now FSMA and...
by admin | Oct 1, 2019 | News & Updates
Sanzyme Biologics has received FAMI-QS certificate for implementing and maintaining a feed management system including good manufacturing practices in line with the FAMI-QS code. FAMI-QS covers all feed ingredients and additives intended for animals as per European...
